# Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report

Source: https://onco.cc/key-papers/paper-siegel-cancer-statistics-2024-cacancer-2024/  
OnCo record `paper-siegel-cancer-statistics-2024-cacancer-2024` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The American Cancer Society's yearly count projected that the United States would pass two million new cancer diagnoses in 2024 for the first time, while the cancer death rate kept falling and colorectal cancer rose to become the leading cause of cancer death in men under 50.

## Summary

Each January the American Cancer Society projects the number of new cancer cases and deaths in the United States and reviews trends in incidence, mortality and survival from national registries. The 2024 report projected 2,001,140 new cancer cases and 611,720 cancer deaths. It reported that the cancer mortality rate had fallen by a third since 1991, averting more than four million deaths, but that incidence was rising for six of the ten most common cancers and shifting towards younger adults, with colorectal cancer now the leading cause of cancer death in men under 50 and the second in women under 50.

## Fields

- Kind: Key paper
- Last checked: 2026-09-08
- Journal: CA: A Cancer Journal for Clinicians
- Year: 2024
- DOI: 10.3322/caac.21820
- Authors: Siegel RL, Giaquinto AN, Jemal A.
- Findings: Projected 2,001,140 new cancer cases and 611,720 cancer deaths in the United States in 2024, the first year above two million cases.; Cancer mortality down by about a third since 1991, an estimated 4.1 million deaths averted.; Incidence rising for six of the ten most common cancers, including breast, prostate, endometrial, pancreatic, kidney and melanoma.; Colorectal cancer the leading cause of cancer death in men under 50 and the second in women under 50.
- What it means: This series is the standard reference for US cancer numbers and the source of most headlines about cancer in younger adults. The gap between falling mortality and rising incidence is the argument for both continued treatment advances and stronger prevention and screening.
- Caveats: Projections, not counts; actual registrations arrive years later.; US-specific patterns do not transfer directly to other countries.

## Sources

- Full text (DOI): https://doi.org/10.3322/caac.21820
- ACS Cancer Facts and Figures: https://www.cancer.org/research/cancer-facts-statistics.html

## Connected records

- key papers: [Bray 2024: GLOBOCAN 2022, the world's cancer count for 36 cancers in 185 countries](https://onco.cc/key-papers/paper-bray-globocan-2022-cacancer-2024/), [Jemal 2007: Cancer statistics, 2007](https://onco.cc/key-papers/paper-jemal-cancer-statistics-2007-cacancer-2007/), [Jemal 2008: Cancer statistics, 2008](https://onco.cc/key-papers/paper-jemal-cancer-statistics-2008-cacancer-2008/), [Jemal 2009: Cancer statistics, 2009](https://onco.cc/key-papers/paper-jemal-cancer-statistics-2009-cacancer-2009/), [Jemal 2010: Cancer statistics, 2010](https://onco.cc/key-papers/paper-jemal-cancer-statistics-2010-cacancer-2010/), [Rahib 2014: projecting US cancer incidence and deaths to 2030](https://onco.cc/key-papers/paper-rahib-projecting-cancer-deaths-2030-cancerres-2014/), [Siegel 2012: Cancer statistics, 2012](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2012-cacancer-2012/), [Siegel 2013: Cancer statistics, 2013](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2013-cacancer-2013/), [Siegel 2014: Cancer statistics, 2014](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2014-cacancer-2014/), [Siegel 2015: Cancer statistics, 2015](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2015-cacancer-2015/), [Siegel 2016: Cancer statistics, 2016](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2016-cacancer-2016/), [Siegel 2017: Cancer statistics, 2017](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2017-cacancer-2017/), [Siegel 2018: Cancer statistics, 2018](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2018-cacancer-2018/), [Siegel 2019: Cancer statistics, 2019](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2019-cacancer-2019/), [Siegel 2021: Cancer statistics, 2021](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2021-cacancer-2021/), [Siegel 2022: Cancer statistics, 2022](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2022-cacancer-2022/), [Siegel 2023: Cancer statistics, 2023](https://onco.cc/key-papers/paper-siegel-cancer-statistics-2023-cacancer-2023/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Endometrial cancer](https://onco.cc/cancers/endometrial/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Melanoma](https://onco.cc/cancers/melanoma/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- terms: [Incidence versus prevalence](https://onco.cc/terms/incidence-vs-prevalence/), [Mortality](https://onco.cc/terms/mortality/)

---
JSON: https://onco.cc/api/v1/entities/paper-siegel-cancer-statistics-2024-cacancer-2024.json